RxDoctor Payments Data

John Slaughter

Adult Health · Chula Vista, CANPI 1962618900

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations.

$1,799in general payments, 2019–2025

Across 77 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$192
  • Merck$166
  • Daiichi Sankyo Inc.$156
  • Pharmacyclics LLC, An Abbvie Company$140
  • Takeda Pharmaceuticals U.S.A., Inc.$124
  • Amgen$95
  • plus $925 from 20 others

What the payments were for

  • Food & beverage$1,69994%
  • Education$1006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,799 in reported general payments places this provider in the 80th percentile of 785 adult health providers in California.

See all adult health providers in California →

Other adult health in Chula Vista

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →